automated, fast, and reliable positioning device that increases procedural accuracy. 4, 34, [36] [37] [38] 56, 59, 60, 62, 63 However, due to high costs, large size, and complex integration into and adaptation of the existing operating room workflow, the use of the available devices is currently limited to larger neurosurgical centers for specialized applications only, such as electrode placements for deep brain stimulation 35 or stereoelectroencephalography, 54 and have not found their way into the routine neurosurgical practice.
Originally designed for needle guidance in interventional radiology, the iSYS1 is a miniature robotic guidance device for aligning a surgical tool along a predefined trajectory with high precision in the submillimeter range. By fixation to a standard 3-pin headholder and connection to a standard neuronavigation system, the iSYS1 robot may be easily integrated into the existing operating room setup in neurosurgery.
The aim of the present study is to evaluate the feasibility and clinical value of the iSYS1 robotic guidance device for intraoperative trajectory alignment in standard neurosurgical procedures, such as needle biopsies and catheter placements.
Methods

Description of the Robotic Guidance Device
The iSYS1 robotic guidance device (iSYS Medizintechnik) is a modular guidance system for surgical invasive tools such as biopsy needles and catheters. 13, 53 It receives spatial data about the predefined trajectory and the present instrument position from a standard neurosurgical navigation system via an Ethernet connection and provides the possibility to precisely align that instrument within this trajectory. After instrument positioning has been completed, the robot's guidance sheath is locked to prevent further motion. The surgeon is then in full control of advancing the instrument along the trajectory to the target point: the iSYS1 robot does not impinge on the surgical procedure by itself, nor does it advance any object into the patient.
The core component of iSYS1 is a 4-axial robot-positioning unit (RPU) (see Fig. 1 , left). The RPU consists of 2 flat modules that can move against one another. Combined with 2 instrument guide extensions, the RPU modules allow precise angulation (± 30°) and translational positioning (± 20 mm) of the instrument guidance sheath with submillimeter precision.
Robot Setup
For the application of iSYS1 in cranial neurosurgery, a rigid connection of the RPU to the patient's head is mandatory for maximum precision. After patient positioning, the RPU was thus attached to the standard 3-pin head holder via a multifunctional arm and a specially designed "Starburst" adaptor ( Fig. 2) . The control unit (see Fig. 1 , right) was then connected to the RPU and the StealthStation S7 navigation system (MDT ST). Patient registration was performed as usual. Then, the robot was manually prepositioned to check the easy adjustment and reachability of the trajectory. Thereafter, it was moved away from the surgical field into the park position for sterile draping.
Preclinical Phantom Study
Prior to clinical application in the operating room setting, we conducted a phantom trial with 3 goals: 1) to optimize operating room setup and workflow, we tested the robot under nonsterile conditions during mock needle biopsy and catheter placement; 2) to design specific robot attachments for biopsy needles and catheters (Fig. 3) ; and 3) to evaluate accuracy and procedural duration, we conduct-
FIG. 1.
The iSYS1 guidance device is composed of the following reusable components: RPU, needle guide extension, and the control unit with a touch screen. Left: The core component is the 4-axial RPU that consists of 2 robotic modules that can be automatically moved against each another. Together with the needle guide extensions, the modules enable submillimeter angulation and translational positioning of the instrument guidance sheath. Right: Control unit with a touch screen (top) and 3 functions: "Home Robot," "Register Robot," and "Move to Plan." After manual prepositioning of the RPU, the software displays if the current position of the guidance sheath allows alignment to the trajectory. ed an experiment under laboratory conditions. Therefore, a human bony skull base that was fitted with 9 titanium screws (3 anterior, 3 middle, and 3 posterior fossa) served as the phantom and was scanned using CT (64-slice General Electric Discovery CT750 HD CT system; nontilted axial scan; 256 slices; 0.625-mm-thick slices; 512 × 512 matrix). Nine entry points were defined along the approximate length of an imaginary calvaria at different angles of less than 45°, 1 for each target. The 9 screw heads served as the biopsy targets.
After receiving basic instructions about the iSYS1 robotic system, 9 neurosurgeons with different levels of experience (4 consultants and 5 residents [1 1st-, 3 2nd-, and 1 3rd-year residents]) performed 162 stereotactic biopsies using either robot-assisted trajectory alignment (n = 81) or manual alignment with a standard manual biopsy arm (Vertek, MDT) under navigational guidance (n = 81). In each case, the target error-defined as the deviation of the biopsy needle tip to the center of the titanium screw head-was measured with a digital caliper. In addition, the instrument positioning time-from selecting the predefined trajectory on the navigation system to the complete insertion of the biopsy needle to the target position-was registered.
Clinical Patient Study
The study was approved by the Ethics Committee of the Medical University of Vienna and the Austrian Agency for Health and Food Safety. The clinical feasibility study was designed to include the first consecutive 25 adult patients treated at the Department of Neurosurgery of the Medical University of Vienna between September 2013 and April 2014. All included patients required a stereotactic biopsy (in 5 patients, this was performed prior to tumor resection) or catheter placement (for the patient characteristics, see Table 1 ) and gave informed consent for their participation in the study.
Target Definition and Trajectory Planning
Within 2 weeks preoperatively, MRI with or without a PET scan ( 11 C-methionine PET on a dedicated, full-ring GE Advance PET scanner [General Electric Medical Systems]) was performed as part of the clinical routine on all patients, as appropriate.
MRI
Patients were examined on a 3-T scanner (Tim Trio, Siemens) using our routine MRI protocol for brain tumors with axial, fluid-attenuated inversion recovery (FLAIR) sequences, diffusion-weighted images, axial and coronal T1-and T2-weighted sequences, and contrast-enhanced (CE) axial, coronal, and sagittal T1-weighted sequences. For accuracy assessment, the axial T1-weighted CE sequence was applied (3D gradient-echo sequence; acquisition time 5.34 minutes; repetition time 1800 msec; echo time 3.79 msec; 256 × 256 matrix; field of view 220 mm; flip angle 12°; 192 slices; 1-mm-thick slices).
PET Scan
Patients received 800 to 850 MBq 11 C-methionine. The PET images were then obtained from a dedicated, fullring GE Advance PET scanner (General Electric Medical Systems 46 and Widhalm et al. 61 In cases of stereotactic biopsy, the target was defined by significant contrast enhancement (CE) on MRI. In the case of nonsignificant CE, the area with the highest PET tracer uptake was selected as the biopsy target. 61 In cases of catheter placement, the center of the cyst or the optimal intraventricular position (defined as free floating in the proximity of the foramen of Monro) was used as the target.
Surgical Workflow
All procedures were performed under general anesthesia. Frameless stereotactic needle biopsies (Fig. 2 , left, and Fig. 4 ) were obtained with optical tracking and surface registration. The iSYS1 robot was always positioned on the side of the patient opposite to the reference frame. After sterile draping, we performed a skin incision and bur hole and dural opening in a standard fashion. Then, manual prepositioning, registration of the robot, and alignment of the trajectory were executed using the optic probe. First, the robot was manually prepositioned at the entry point within its 4 × 4-cm workspace. After exact automatic positioning, the skin incision was marked and the robot was moved out of the surgical space automatically. After skin incision and bone exposure, the robot was automatically repositioned and the exact bur hole was marked and drilled through the robotic guidance sheath. The probe was then exchanged for a navigated 2.2-mm-diameter Nashold biopsy needle, which was advanced to the target under continuous depth guidance by its 2 passive markers. Samples were taken at the target and other points at various angles as appropriate. Frozen sections were not routinely obtained at our department. The biopsy procedure could be terminated after sampling a single target if 5-aminolevolinic acid fluorescence was strongly positive at this point (for additional details, see Widhalm et al. 61 ). In 5 cases, a stereotactic biopsy was performed in a standard fashion prior to tumor resection.
Intracranial catheter placements (Fig. 2 , right) were navigated with electromagnetic (EM) tracking. The iSYS1 robot was always positioned on the side of the patient opposite to the EM-field emitter. The EM stylet, which is a 1.2-mm-diameter, insulated, metallic wire with 2 copper coils for EM-field detection close to its tip, served as a probe for position identification. By insertion into hollow instruments, such as shunt catheters, the stylet was used for intraoperative, continuous tip tracking.
After sterile draping, skin incision and standard bur hole and opening of the dura were performed. Then, manual prepositioning, registration of the robot, and alignment with the trajectory were executed using the EM stylet. The stylet was then inserted into the hollow catheter and advanced through the guidance sheath to the target position under continuous navigational guidance.
Accuracy Assessment
Registration accuracy was checked using anatomical landmarks, as described previously. 64 If judged inaccurate, registration was repeated.
The trajectory alignment error (TAE)-a parameter for axial deviation between the instrument and the preplanned trajectory-is automatically calculated by the navigation system and continuously displayed by the "biopsy procedure" software module. The real target error (RTE)-a parameter that defines how accurately a procedure reaches the target within a given patient-was assessed on routine postoperative CT or MRI that was performed within the first 48 hours from air bubbles, biopsy canals, or radiopaque catheter tips. We performed image fusion of the preoperatively planned trajectory with the postoperative images and measured the maximum deviation at the entry and target points in the x-and y-planes (the z-plane was excluded as it is not dependent on the robot, but solely on the surgeon advancing the instrument). Postoperative images were obtained on an identical CT/MRI scanner. Due to the image resolution of < 1 mm for CT and the in-plane resolution of MRI, the navigation system's calculated resolution of 0.1 mm was used for our results.
Operating Room Time Related to the Application of the Robotic System
We assessed 2 time durations related to the application of the robotic system (Fig. 5 ). 1) The setup time consisted of mechanical fixation, connection and startup of the robot, navigation setup and registration, checking the reachability of the entry point, placement of sterile covering, and insertion of the instrument guidance sheath. 2) The instrument positioning time consisted of robot prepositioning, registration, and targeting.
Clinical Outcome
For tumor biopsy, the diagnostic yield was calculated as the rate of representative samples as established by the   FIG. 4 . iSYS1 intraoperative workflow for stereotactic biopsies. A: The patient's head is fixed with a standard Mayfield clamp. The RPU and patient reference frame are attached to the "Starburst" adaptor. After manual prepositioning of the RPU (B), the reachability of the RPU to a certain trajectory is assessed on the navigation and control unit screen, or the Vertek probe in the case of optical tracking (C). D: Sterile draping of the RPU and the multifunctional arm, and the fixation of the sterile instrument guidance sheath. E: After exact localization of the optimal position, skin incision, and drilling of the bur hole, the iSYS1 robot is moved sideways to allow a clear view on the operation site without occupation of the surgeon's working space. F: After dura opening and coagulation, the navigated 2.2-mm-diameter Nashold biopsy needle was advanced to the target through the reduction sheath under continuous depth guidance. local neuropathology team according to the 2007 WHO criteria. 39 For catheter placement, we classified the position of the catheter tip on the postoperative CT scan according to the criteria of Hayhurst et al. as 1) free floating in CSF/cyst cavity, 2) touching the choroid, ventricular, or cyst wall, or 3) intraparenchymal. 23 Postoperative hemorrhage was classified according to the location (target site or along the trajectory) on early, routine, postoperative CT scans. Procedure-related clinical status changes were assessed at discharge and at early postoperative follow-up and compared with the preoperative status.
Statistical Analysis
For the statistical analysis, SPSS software (version 22.0; SPSS Inc.) was used. Within the scope of the preclinical phantom study, we compared the mean target error and mean procedural durations of the iSYS1-assisted procedures with the standard biopsy-arm method using the paired t-test. Values were given as the mean and standard deviation or median and range. A p value of < 0.05 was considered significant.
Results
Preclinical Phantom Study
After operating room setup and workflow optimization, 162 stereotactic biopsies were performed by 9 neurosurgeons with different levels of experience (4 consultants and 5 residents [1 1st-, 3 2nd-, and 1 3rd-year residents]) either with robot-assisted trajectory alignment (n = 81) or manual alignment using a standard mechanical biopsy arm (Vertek, MDT) (n = 81) under navigational guidance. For adaptation of the robot design and instrument attachments, see Fig. 3 . The mean target error was significantly lower if robotic needle guidance was used (mean 0.6 mm and range 0.1-0.9 mm for robotic guidance vs mean 1.2 mm and range 0.1-2.6 mm for the manual biopsy arm; p < 0.001, paired t-test).
The mean procedural duration from selection of the preplanned trajectory on the navigation system to complete insertion of the biopsy needle at the target position was significantly shorter if robotic needle guidance was used (mean 2.6 minutes and range 1.3-5.5 minutes for robotic guidance vs mean 3.7 minutes and range 2.0-10.5 minutes for manual biopsy arm; p < 0.001, paired t-test) ( Table 2) .
Clinical Patient Study
Feasibility
In 24 of 25 patients, application of the iSYS1 robotic device was feasible. The procedure was abandoned in Case 5 (tumor biopsy) due to an error caused by selecting the nonprimary of 2 merged data sets for patient registration, resulting in the deviation of the robot by the distance of the 2 image stacks. This action was not previously known to cause erroneous system behavior, and the procedure was immediately converted to a standard frameless biopsy using a manual arm. In all of the following cases, the primary merged data set was used for patient registration to prevent the reoccurrence of this error. A request for software modification has been forwarded to the manufacturer.
In the remaining 24 patients, frameless stereotactic biopsy (for an illustrative patient, see Fig. 6 ) was performed in 16 (67%) patients (5 of these patients had stereotactic biopsy performed immediately prior to tumor resection), ventricular catheter placement in 5 (21%) patients, and stereotactic cyst drainage in 3 (12%) patients. For detailed patient characteristics, see Table 1 .
In the cases of stereotactic biopsy, a single target was selected in 14 of 16 patients (the area of CE on MRI in 11 patients or the area of maximum tracer uptake in 3 patients), and 2 targets were sampled in 2 of 16 patients (the area of CE on MRI plus the area of highest PET tracer uptake).
The median lesion volume was 30.5 ml (range 0.7-235.5 ml), and the median biopsy target volume was 2.9 ml (range 0.5-46.0 ml) ( Table 3) .
Twenty-one patients were positioned supine, 3 patients were positioned prone, and 1 patient was positioned sitting. In cases of stereotactic biopsy and cyst drainage, the robot was always positioned on the contralateral side of the lesion, and in cases of shunt implantation the robot was positioned on the contralateral side of the distal catheter in order to not interfere with subcutaneous cervical tunneling. Because the robot was always positioned opposite to the EM-field emitter and the robot was made of nonferromagnetic material (glass fiber-reinforced polyamide), we did not encounter tracking problems using the robot.
Accuracy Assessment
The TAE for optical tracking was either 0.0 (50% of cases) or 0.1 mm (50%). The median TAE for electromagnetic tracking was 0.7 mm (range 0.2-2.4 mm).
The median RTE for optical and EM guidance was 1.3 mm (range 0.2-2.6 mm) at entry and 0.9 mm (range 0.0-3.1 mm) at the target points (Table 3) . Patients who underwent resection after the initial stereotactic biopsy could not be included in the postoperative accuracy assessment.
Operating Room Time Related to the Application of the Robotic System
The median setup time for the navigation system and robot was 11.8 minutes (range 4.2-26.7 minutes), the overall median incision to suture time was 14.7 minutes (range 7.0-28.3 minutes): 15.7 minutes (range 7.0-28.3 minutes) for biopsies and 11.6 minutes (range 8.9-27.3 minutes) for catheter placements. The median instrument positioning time was 4.9 minutes (range 3.1-14.0 minutes) ( Table 3) .
Clinical Outcome
No robotic device-related adverse effects were observed. In the frameless stereotactic biopsy procedures, a diagnostic tissue sample could be obtained from all patients, corresponding to a diagnostic yield of 100%. In all 5 cases of shunt placement, satisfactory functional catheter position was achieved. The catheter tip position was free floating in the vicinity of the foramen of Monro in 3 patients, and in 2 patients the tip position was inside the ventricle adjacent to the ependymal wall due to narrow ventricles (Table 4 ).
An intralesional hemorrhage at the target position was observed on the first postoperative CT scan in 3 patients (12.5%), which measured 10, 12, and 15 mm in diameter, and no hemorrhage was detected along the trajectory (Table 4). Transient clinical deterioration during the hospital stay was observed in the following patients: one patient (Case 6) experienced a transient aggravation of the preexisting left hemiparesis, another (Case 9) showed memory disturbance, and a final patient (Case 21) experienced transient vertigo and disorientation. During the admission period, all 3 patients recovered to their preoperative neurological condition. Thus, permanent clinical deterioration was not observed in any case. No infections occurred in any of the cases.
Discussion
Stereotactic procedures are among the most frequently performed procedures in cranial neurosurgery. To overcome the limitations of frame-based, frameless, or even free-hand techniques, 1, 3, 5, 6, 11, 15, 16, 36, 44, 45, 55 robotic systems have been introduced that are aimed at a more accurate and hence safe procedure. 4, 33, 34, 59 In this report, we introduce iSYS1-a novel miniature robotic system for neurosurgical stereotactic interventions-and demonstrate that iSYS's major advantage is its seamless integration into the operating room setup due to its miniature design.
Workflow
Its miniature size and easy handling allowed the convenient integration of the iSYS1 robotic system into the workflow of our routine neurosurgical procedures. The preexisting navigation system could be used for trajectory planning and navigation of the robot, eliminating the need for acquisition and training on new navigation hardware and software. The preexisting skull clamp and multifunctional arm could be used for rigid fixation of the robot to the patient's head. The sleeve provided by the manufacturer allowed for fast sterile draping, and the introduction of the robot's instrument guide extensions through this sterile drape was found to be unproblematic.
Patient registration was performed by the navigation system's standard 3D surface registration. Because the registration method of our system is solely dependent on the navigation system, and not on the robot, 3D surface registration was possible in any given position. This is beneficial in comparison with other available robots. For example, Lefranc et al. reported that the ROSA robotic device was unable to surface register the face in the prone position, and thus skin fiducials were necessary in these cases.
34
The robot was always positioned on the side opposite of the patient reference frame, leaving the surgeon's and assistant's positions unaffected. When the robot was not in use, it was pivoted sideways. In this parked position, the robot did not interfere with the ongoing surgical procedure, such as tumor resection or peritoneal catheter placement, due to its small size. If necessary, repositioning of the OR table was possible throughout the whole surgical procedure due to the miniature and light-weight design that allow the movements of the iSYS1 robot. This seems advantageous over robots that are floor based and do not allow patient repositioning or operating room table movements once they are rigidly fixated to the patient's head.
34,59
Feasibility
The clinical application of iSYS1 was feasible in all but 1 patient: in Case 5, we inadvertently chose the nonprimary of the 2 merged data sets for registration, resulting in the deviation of the robot by the distance of the 2 image stacks. This deviation was detected immediately by the misalignment of the instrument on the navigation screen. Because the cause of the error could not be interpreted intraoperatively, we converted the procedure to a manual arm-based frameless biopsy. Under laboratory conditions, the error could be reproduced and the correct choice of data sets was guaranteed in all following cases.
Extreme Targets
In contrast to a frame-based setup, trajectories to "extreme" locations (e.g., low temporal lobe, posterior fossa) were also feasible with our robotic system. This is in line with the reports of experiences using other available robots. 34 
Multiple Bilateral Targets
As with other systems, robotic instrument movements from one to another trajectory are possible with iSYS1. However, if the entry point distances of the 2 trajectories exceed the range of the translational positioning workspace of the iSYS1 robot (40 × 40 mm), such as in the case of bilateral targets, manual repositioning of the device is necessary. Due to the wider range of motion, this is not necessary with arm-based robotic devices. 4, 34, 36, 59 However, the convenient handling, low weight, and miniature design of the iSYS1 robot considerably facilitated this repositioning.
Safety
iSYS1 robotic movements are only possible in the x-and y-directions, and the surgeon remains in control of instrument insertion into the cranium at all times. For security reasons, a dead man's switch must be pushed continuously to enable robotic movements. Inadvertent robotic movements without the surgeon's interactions are therefore not possible. According to our experience, the system assembly proved to be highly stable throughout the procedures, as the maximum payload of the components (36 kg for the skull clamp and 10 kg for the multifunctional arm) was not exceeded by the 1.35-kg robotic device and the weight of the patient's head.
Accuracy
Although still considered the gold standard for high accuracy, 29, 43, 52, 65 frame-based stereotaxy has been replaced by frameless navigation-guided procedures in most neurosurgical departments worldwide due to their time savings, higher flexibility in the working space, and improved target visualization. 3, 5, 6, 11, 15, 16, 44, 45 Robotic guidance may combine the straightforward and convenient application of frameless navigation guidance with high accuracy. Accuracy at the target is the most relevant parameter of a stereotactic neurosurgical procedure and is usually defined by the RTE. The RTE of a navigation-guided stereotactic procedure is derived from the following factors: 1) The technical or system error indicates how reliably a navigation system can define its own position in space. 18, 19 In modern neuronavigation systems, it accounts for less than 0.12 mm with optical tracking and less than 0.37 mm with EM tracking. 30 The technical error is inherent in the navigation system, and therefore cannot be improved by the user. 18, 19 2) The registration is a mathematical process in which 2 different coordinate systems are related to each other by selecting common marked points in both coordinate systems 36 ; therefore, the registration error is the inaccuracy that results from aligning the patient's head with the radiological image data. It depends on the imaging distortion (0.23 ± 0.03 mm for CT with 1-mm-thick slices, 7 and < 0.4 mm for MRI depending on the field strength and static field inhomogenities 41, 57 ), slice thickness, and the method used for intraoperative registration. The error is less than 0.5 mm bone screw registration, 30 2 mm for skin fiducials, 18,47 2.5 mm for surface registration, 18, 42 and 3.3 mm for anatomical landmarks. 64 In the clinical routine, the method of registration is usually chosen according the size and location of the lesion. Bone screw registration is appropriate for small lesions in the brainstem, whereas surface registration is sufficient for large hemispheric lesions. 3) TAE is dependent on accurate instrument positioning along the predefined trajectory. By using robotic instrument positioning, TAE can be significantly reduced. Our preclinical data showed that the RTE could be significantly improved by using the iSYS1 robot compared with the manually adjustable biopsy arm (mean RTE 0.6 mm vs 1.2 mm, respectively; p < 0.001). These data were confirmed in a clinical setting, as we observed a mean deviation of only 0.05 ± 0.06 SD in our clinical cases.
Consequently, by using our robotic device, RTE can be reduced to the technical error of the system itself and the registration error.
For the assessment of the RTE, we initially used an intraoperatively applied air bubble. However, this was found to be inaccurate, and hence RTE was calculated by including the biopsy canal tip on postoperative MRI or the catheter tip on postoperative CT instead (Table 3) . Using this method, we calculated a median RTE at the target position of 0.9 mm (range 0.0-3.1 mm) in our series, which compares very well with the reports of other robots that use surface registration. 33, 59 As surface registration was used in all cases, these results seem plausible.
Timing
One of the main advantages of frameless stereotaxy compared with frame-based procedures is a reduction in the operating room time. 11 To evaluate iSYS1 with regard to timing, we first assessed the instrument positioning time-which consists of robot prepositioning, registration, and targeting within the scope of our preclinical studyand compared it to our frameless manual instrument positioning. Although the users were unexperienced with the robotic system, the use of the robotic system resulted in a 30% reduction in positioning time. This is in line with the reports of other neurosurgical robotic systems. 4, 34 With regard to the additional robot time expenditure, the robot used in this study showed a clear advantage over other existing robots. With our workflow consisting of fixation, connection and startup of the robot, placement of sterile covering, and insertion of the instrument guidance sheath, only minimal additional time is necessary compared with the standard operating room setup (median 8.6 minutes; range 2.5-19.6 minutes).
In contrast to our experience with iSYS1, Lefranc et al. reported significantly longer operating room occupation due to installation, draping, and scanning of the ROSA robot (< 1 hour for the robot only and < 2 hours for the robot plus an O-arm and bone fiducials). 34 Although Bekelis et al. reported a significant reduction in operating room time (mean operating room time 44.6 minutes) 4 between the first and the second half of the patient cohort, no details were given regarding the duration of image importation and robot setup. 4 Moreover, a fast learning curve is one of the major advantages of the iSYS1 robotic system. We observed a slight decrease in the median setup time over the course of this study: the median setup time was 14.6 minutes for the first third, 12.1 minutes for the second third, and 10.3 minutes for the last third of the study cohort.
Diagnostic Yield
A diagnostic tissue sample could be obtained from all patients. Thus, the diagnostic yield of this series was 100%, which compares well with the existing literature. 2, 5, 8, 9, 21, 22, 25, 51, 58, 66 
Complications
Hemorrhage
We observed a hemorrhage on the postoperative CT scan (range 10-15 mm) in 3 of our 24 patients (12.5%) with a median diameter of 12 mm, which resulted only in transient clinical deterioration. All hemorrhages were located inside the lesion, and none were found along the trajectory, possibly due to meticulous trajectory planning on CE MRI in order to avoid vasculature. This hemorrhage rate is again comparable with previous studies that report intracranial hemorrhages 10, 50 in 0.3% to 59.8% of the cases. 8, 9, 17, 28, 31, 32, 40, 43 For instance, from a large series of 41 patients who were operated on with the SurgiScope robotic system (Intelligent Surgical Instruments & Systems), Bekelis et al. reported a 97.8% diagnosis rate, 2% rate of transient morbidity, and 2% rate of permanent neurological deficit. Postoperative hemorrhage was seen in 9.8% of the patients. 4 Willems et al. reported on the successful use of the MKM instrument holder (Carl Zeiss) in a series of 23 patients with a diagnostic yield of 95% and a 5% rate of transient morbidity. 62 The NeuroMate robotic system (Renishaw), which uses a passive robotic biopsy arm, was the first Food and Drug Administration-approved robotic system for a neurosurgical application. 36, 59, 60 In a series of 17 brainstem biopsies, this robotic device demonstrated a diagnostic yield of 86%, permanent clinical deterioration in 6%, and transient morbidity in 13% of patients. 20 In a large series of 100 consecutive frameless stereotactic biopsies, the ROSA robotic device could achieve a 97% rate of diagnostic samples with a 10% rate of hemorrhage and 8% rate of transient morbidity. 34 In terms of diagnostic yield and morbidity, our series of stereotactic robotic biopsies with iSYS1 compares well the results of other robotic systems 4, 34, 59, 62 and conventional frame-based or frameless stereotactic biopsies. 1, 3, 5, 8, 16, 43, 65 
Limitations and Outlook
Due to the limited number of patients, our preliminary series does not allow a subgroup analysis of different procedures in order to draw significant conclusions. However, this study was only designed to evaluate the feasibility of the iSYS1 robotic device for neurosurgical procedures prior to larger trials. Furthermore, the clinical part of this study lacks a control group for comparison with the standard frameless manual method. Again, this was beyond the scope of this feasibility study.
Future studies will focus on the application of iSYS1 for epilepsy surgery (depth electrode placement for stereoelectroencephalography), functional neurosurgery (deep brain stimulation), and endoscopic neurosurgical interventions (endoscopic third ventriculostomy).
Conclusions
Intraoperative application of the iSYS1 robotic guidance device was feasible for frameless stereotactic biopsies and shunt and catheter placements in the vast majority of cases. Due to its miniature size and convenient handling, we experienced a seamless integration of the robot into the existing OR workflow with a short learning curve.
According to our preclinical data, the iSYS1 robot can significantly improve accuracy while reducing instrument positioning time. Our clinical application demonstrated high accuracy and short setup and instrument-positioning times. Future developments will focus on depth electrode implantations, endoscopic interventions, and functional neurosurgery.
